The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Powell, M. S.
Right arrow Articles by Hogarth, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Powell, M. S.
Right arrow Articles by Hogarth, P. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-PROLINE
*L-SERINE
*METHOTREXATE
The Journal of Immunology, 2006, 176: 7489-7494.
Copyright © 2006 by The American Association of Immunologists

Alteration of the Fc{gamma}RIIa Dimer Interface Affects Receptor Signaling but Not Ligand Binding1

Maree S. Powell*, Nadine C. Barnes*, Tessa M. Bradford*, Ian F. Musgrave{dagger}, Bruce D. Wines*, John C. Cambier{ddagger} and P. Mark Hogarth2,*

* The Macfarlane Burnet Institute for Medical Research and Public Health Limited, Austin Health, Heidelberg, Victoria, Australia; {dagger} Department of Clinical and Experimental Pharmacology, Adelaide University, Adelaide, Australia; and {ddagger} Integrated Department of Immunology, University of Colorado Health Sciences Centre, and National Jewish Medical Center, Denver, CO 80206

The aggregation of cell surface FcRs by immune complexes induces a number of important Ab-dependent effector functions. However, despite numerous studies that examine receptor function, very little is known about the molecular organization of these receptors within the cell. In this study, protein complementation, mutagenesis, and ligand binding analyses demonstrate that human Fc{gamma}RIIa is present as a noncovalent dimer form. Protein complementation studies found that Fc{gamma}RIIa molecules are closely associated. Mutagenesis of the dimer interface, as identified by crystallographic analyses, did not affect ligand binding yet caused significant alteration to the magnitude and kinetics of receptor phosphorylation. The data suggest that the ligand binding and the dimer interface are distinct regions within the receptor, and noncovalent dimerization of Fc{gamma}RIIa may be an essential feature of the Fc{gamma}RIIa signaling cascade.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. F. Arthur, Y. Shen, M. L. Kahn, M. C. Berndt, R. K. Andrews, and E. E. Gardiner
Ligand Binding Rapidly Induces Disulfide-dependent Dimerization of Glycoprotein VI on the Platelet Plasma Membrane
J. Biol. Chem., October 19, 2007; 282(42): 30434 - 30441.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.